Examinando por Materia "Cost-Benefit Analysis"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    PublicaciónAcceso abierto
    Impacto económico del fraccionamiento de antibióticos de uso intravenoso administradas en jeringas precargadas en pacientes neonatos de un hospital de Lima Metropolitana durante los meses de enero a marzo del 2017
    (Universidad Privada Norbert Wiener, 2017-12-07) Becerra Zegarra, Paola Patricia; León Soria, Narciso Enrique
    This study is a descriptive, retrospective, and cross-sectional analysis with the objective of determining the economic impact of fractionating intravenous antibiotics into pre-filled syringes for neonatal patients at a Metropolitan Lima Hospital from January to March 2017. The worksheets from the Centralized Intravenous Admixture Unit for the first quarter of the year were analyzed. It was determined that a total of 8,951 pre-filled syringes were prepared. This method generated a savings of 6,093 ampoules, which translated into an economic saving of 31,165.33 Peruvian soles. Of the nine antibiotics studied, the one with the highest turnover was Vancomycin (47.2%), followed by Meropenem (20.8%), Imipenem (20.3%), and Amikacin (8.4%). It is concluded that the Centralized Intravenous Admixture Unit adequately optimizes resources by fractionating intravenous antibiotics into pre-filled syringes. This enables the hospital to serve a greater number of neonatal patients, with appropriate equipment and highly trained personnel to provide reconstituted medications under optimal conditions for administration.